 |
|
|
|
|
|
|
| Article 1 to 9 out of 9 concerning Sequenom, Inc.
|
-
Sequenom Announces Exclusive Licensing Agreement with Genomic Nanosystems for Digital PCR Technologies and Methods Patents
(24 Sep 2008)
Sequenom, Inc. announced that it has secured exclusive rights to fundamental patent rights for digital PCR technologies and methods through a licensing agreement with Genomic Nanosystems, LLC, a wholly owned subsidiary of the Cytonix Corporation. ...
-
Sequenom to Begin Clinical Assessment of Noninvasive Screening Technology for Down Syndrome
(25 Jan 2008)
Sequenom, Inc. announced the approval of a protocol by the Institutional Review Board (IRB) at San Diego-based Sharp HealthCare, clearing the way to commence patient enrollment in a screening study to clinically assess the Company's noninvasive cell ...
-
Sequenom Announces New York State Approval of a Noninvasive Prenatal Test for Rhesus D Incompatibility
(03 Jan 2008)
Sequenom, Inc. announced the New York State approval of the first noninvasive prenatal test based on Sequenom's SEQureDx(TM) Technology for Cell Free Fetal Nucleic Acid assessment. The Laboratory Developed Test (LDT) performed on a real-time PCR ...
-
Sequenom and Lenetix Enter Agreement to Develop and Commercialize Rhesus D Prenatal Diagnostic
(31 Jan 2007)
Sequenom, Inc. and Lenetix Medical Screening Laboratory, Inc., a provider of rapid genetic screening and diagnostic testing, announced that they have entered into a collaboration and license agreement to develop and commercialize a proprietary ...
-
Sequenom and Genus Enter Into Large Scale Livestock Genotyping Services Contract
(19 Jan 2007)
Sequenom, Inc. announced that it will provide contract genotyping services to Genus plc, a company applying quantitative genetics and biotechnology to livestock breeding, for a number of large-scale, high-throughput genotyping projects aimed at ...
-
SEQUENOM Secures Rights to Key Non-Invasive Prenatal Diagnostic Intellectual Property
(24 Oct 2005)
SEQUENOM, Inc. has acquired exclusive rights in certain countries including the United States, United Kingdom and other countries in Europe and elsewhere, to non-invasive prenatal diagnostic intellectual property from Isis Innovation Ltd., the ...
-
Researchers Discover Gene Believed Responsible for Age-Related Macular Degeneration
(14 Mar 2005)
Researchers from Boston University School of Medicine (BUSM), University of Texas Southwestern Medical Center at Dallas (UT Southwestern), and SEQUENOM, Inc. report the discovery of a genetic variation that is the strongest known risk factor ...
-
SEQUENOM and Siemens Form Joint Working Group on Molecular Diagnostics
(29 Oct 2004)
SEQUENOM, Inc. announced the formation of a joint working group with Siemens Medical Solutions of Siemens AG to explore the requirements for next generation molecular diagnostics platforms."We are interested in novel platforms for different nucleic ...
-
MassARRAY(TM) System Enables Detection of Fetal Genetic Mutations in Maternal Plasma
(13 Jul 2004)
Technology has the Potential to Replace Widely Used Risky and Expensive Diagnostic Procedures
San Diego. SEQUENOM, Inc. announced that through a collaboration with an international consortium led by The Chinese University of Hong Kong (CUHK) and Boston University (BU) a novel process to determine genetic mutations in circulating fetal ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon